Literature DB >> 56411

Relation of e antigen to hepatitis B virus infection in an area of hyperendemicity.

J E Maynard, D H Barrett, B L Murphy, D W Bradley, K R Berquist, T R Bender.   

Abstract

A study of the e determinant of hepatitis B surface antigen in an area of hepatitis B hyperendemicity revealed that the presence of e antigen or of antibody to e in the sera of individuals was specifically related to evidence of past or present infection with hepatitis B virus. Among asymptomatic long-term carriers of hepatitis B surface antigen, presence of the e antigen was associated with elevated levels of aspartate and alanine aminotransferases in serum; this observation suggested that the e antigen might be a marker for persisting hepatic dysfunction. Higher levels of DNA polymerase found in carriers of the surface antigen with e antigen suggested that these individuals might have a higher level of circulating Dane particles and thus, perhaps, a higher level of hepatitis B virus infectivity.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 56411     DOI: 10.1093/infdis/133.3.339

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Quantitative correlation between the Dane particle-associated DNA polymerase and the hepatitis B e antigen.

Authors:  W Siegert; J Grunst; W Wilmanns; G G Frösner; F Deinhardt
Journal:  Infection       Date:  1979       Impact factor: 3.553

2.  Hepatitis B surface antigen-specific cell-mediated immune responses in human chronic hepatitis B surface antigen carriers.

Authors:  K R Beutner; M L Tiku; P L Ogra
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

3.  Purification and partial characterization of hepatitis e antigen (HBeAg).

Authors:  H A Fields; D W Bradley; C L Davis; J E Maynard
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

4.  Hepatitis B surface antigen in saliva, impetiginous lesions, and the environment in two remote Alaskan villages.

Authors:  N J Petersen; D H Barrett; W W Bond; K R Berquist; M S Favero; T R Bender; J E Maynard
Journal:  Appl Environ Microbiol       Date:  1976-10       Impact factor: 4.792

5.  Hepatitis B e-antigen titres for evaluating infectivity during hepatitis B virus infection.

Authors:  E G Lindenschmidt; C F Granato; C Salefsky; R Laufs; H Henning
Journal:  Klin Wochenschr       Date:  1984-03-01

6.  Duality of hepatitis B e antigen in serum of persons infected with hepatitis B virus: evidence for the nonidentity of e antigen with immunoglobulins.

Authors:  K Takahashi; M Imai; Y Miyakawa; S Iwakiri; M Mayumi
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

7.  Difference in the distribution of e antigen among different ethnic groups in a population of blood donors.

Authors:  G Richer; D Phaneuf; F Boisvert; R Guévin; A Viallet
Journal:  Can Med Assoc J       Date:  1977-04-09       Impact factor: 8.262

8.  Expression of hepatitis B virus-specific markers in asymptomatic hepatitis B surface antigen carriers.

Authors:  G H Arnold; J W Shih; P M Kaplan; R H Purcell; J L Gerin; K H Bueschenfelde
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

9.  Host specificity of a serum marker for hepatitis B: evidence that "e antigen" has the properties of an immunoglobulin.

Authors:  A R Neurath; N Strick
Journal:  Proc Natl Acad Sci U S A       Date:  1977-04       Impact factor: 11.205

10.  Association of e antigen with Dane particle DNA in sera from asymptomatic carriers of hepatitis B surface antigen.

Authors:  B G Werner; A P O'Connell; J Summers
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.